Serum prostate specific antigen levels during hyperthermia treatment of benign prostatic hyperplasia.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1700150.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To understand better the tissue and cell changes occurring in the human prostate as a reaction to heat, we used circulating prostate specific antigen as a marker to detect cell injury. The prostate in 18 patients with benign prostatic hyperplasia was heated to 42 +/- 1.5C with local microwaves at 915 MHz. Each treatment sessions lasted 1 hour and the patients underwent 5 treatment sessions. A total of 90 treatment sessions was performed among 18 patients. No significant difference was observed between pre-treatment and post-treatment serum prostate specific antigen levels. We conclude that local hyperthermia is an atraumatic treatment modality that does not exert its effect on the hyperplastic prostate via a cytotoxic insult to prostate epithelial tissues.
Medical subject headings
- Antigens, Neoplasm
- Biomarkers, Tumor
- Hyperthermia, Induced
- Microwaves
- Prostatic Hyperplasia